Skip to main content
Fig. 6 | Journal of Experimental & Clinical Cancer Research

Fig. 6

From: Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis

Fig. 6

The expression of GAS5 in cytoplasm could be elevated by Rapamycin. a The mRNA and protein level of GAS5 were assessed by RT-qPCR in OC cell lines treated by Rapamycin. b Cy3-labeled GAS5 and DAPI-labeled U6 probes were obtained from RiboBio. RNA FISH were performed using fluorescent in situ hybridization kit (RiboBio) according to manufacturer’s instructions. c Flow cytometry assay were performed to detect the cell cycle impacted by Rapamycin treating in OC cell lines SKOV3 and HEY. *P < 0.05 versus control groups

Back to article page